About Us

SilaBio was born out of intense desire to make a difference in horrific genetic disorders with unmet need.  It's three Founders put patients first.  We are a well-rounded team comprised of an MD, a PhD and a rare disease mom turned citizen-scientist.  Together, we will succeed and make miracles happen for generations to come.

Giant Axonal Neuropathy (GAN) is a multi-system neurodegenerative disorder.  The GAN gene regulates intermediate filament proteins involved in the disease pathology of many fatal disorders. It also regulates a gene involved in cancer metastasis which we are investigating pre-clinically. 

SilaBio is focused on developing treatments for GAN and translating our discoveries to more prevalent indications.

We are validating new outcomes technology and are patent protecting assets to insure we will raise the capital needed to impact the precious and innocent lives depending on us.